Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies

NCT06700564 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT06700564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06700564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies
Lead sponsor
Shanghai East Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
December 1, 2024
Completion date
November 30, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatoma